Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sandeep Soni, MD
Researcher Executive Director
CRISPR Therapeutics, Inc.
610 Main Street
Cambridge, Massachusetts, United States
Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies.
Areas of Interest-
– Cellular Therapy
– Gene Therapy
– Stem Cell Transplant
– Sickle Cell Disease
– Thalassemia
– Reduced Intensity Conditioning
Clinical Focus-
– Hematology/Oncology
– Stem Cell Transplant and Gene Therapy
+myBinderRelated Content
-
Lanetta Bronté-Hall, MD, MPH, MSPHLanetta Bronté-Hall, MD, MPH, MSPH, is ...
-
CMO Speaks: Making ED Care Better for SCD – Progress in 2023Welcome to CMO Speaks, a blog featuring ...
-
James D’Olimpio, MD, FACP, FAAHJames T. D'Olimpio, MD, FACP, FAAHPM is ...
-
UConn Health / New England Sickle Cell InstituteThe New England Sickle Cell Institute at...
-
High ED Utilization and Perceptions of Opioid Addictionhttps://www.youtube.com/watch?v=9xJ4VwtB...
-
The Regional Comprehensive Sickle Cell Center at Robert Wood Johnson Medical SchoolThe Division of Hematology provides spec...
-
A systematic review of the literature for severity predictors in pediatric sickle cell anemia patientsBackground: All patients with HbSS (SCA)...
